Drug intelligence / Profile preview

L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide

Development stage: Unknown
Modality: Small Molecules
Administration: Subcutaneous

Overview

L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide is a chemical compound with the molecular formula C16H25N3O3. It is classified as a pharmaceutical compound and is listed in databases such as PubChem (CID 46937118) and ZINC15. While its exact mechanism of action and primary indication as a standalone drug are not readily available in public databases, its classification suggests potential pharmaceutical relevance. It is a small molecule, but specific details regarding its development, therapeutic use, or developers are not widely published under this exact name.

Targets

KLK7

Beyond the preview

Go deeper on L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide.

Explore the full profile